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ABSTRACT  - 265 (MAX: 200) 
 
Renal squamous cell carcinoma is a rare primary tumour of the kidney, which rapidly 
invades local structures and has a poor prognosis.  Presentation is usually non-
specific and is associated with renal stone disease, chronic infection and excessive 
analgesia use.  
 
A 46-year-old white male with renal stone disease and recurrent urinary infections 
underwent a right nephrectomy and subsequent renal transplantation due to failure 
of the remaining left kidney. Five years post-transplant, an abdominal ultrasound 
scan was performed due to recurrent urinary infections and ongoing pyuria.  This 
was reported as normal, but he later developed a discharging sinus in his left flank.  
A CT scan of his abdomen revealed a tracking peri-nephric abscess with an 
associated cystic lesion of the left kidney.  A left nephrectomy was performed and 
histological examination suggested an invasive squamous cell carcinoma of the renal 
pelvis.  The patient later developed chronic infection at the left nephrectomy site 
requiring major surgery and further imaging revealed metastatic disease.  The 
decision was made to manage palliatively, as he was too unwell to receive 
chemotherapy.   
 
Renal transplant recipients are three-four times more likely to develop a malignancy 
than the general population.  Given the patient also had renal stone disease and 
recurrent urinary infections, he was at a greater risk of developing this condition.  
Unfortunately the abdominal ultrasound was unhelpful and only a later CT scan 
revealed the underlying malignancy. Given the non-specific nature of the symptoms 
and the poor prognosis, healthcare professionals should have a lower threshold for 
diagnostic imaging in these patients. In addition, this should be expedited if there is 
a persistent abnormality on urinalysis. 
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Primary tumours of the kidney are relatively rare accounting for only 3% of all 
malignancies[1].  Renal cell carcinoma is by far the most common type, followed by 
transitional cell carcinoma, which together represent over 90% of primary kidney 
tumours.  Squamous cell carcinoma of the kidney is a much rarer condition, 
accounting for around 8% of primary kidney tumours[2]. There is an equal sex 
distribution and it most commonly affects those between 50-70 years old[2].  It is 
usually advanced at diagnosis and carries a poor prognosis. It is associated with long 
standing renal stone disease (particularly staghorn calculi[3]), chronic kidney 
infection[4], hydronephrosis and analgesic abuse[5].  The physical examination is 
usually unremarkable and presenting features are non-specific but may include 
abdominal pain or fullness and haematuria.  Similar to squamous carcinoma of the 
lung, these tumours can be associated with paraneoplastic syndromes such as 
hypercalcaemia and Cushing’s syndrome. 
Renal transplant recipients are three-four times more likely to develop a malignancy, 
notably skin (particularly squamous cell carcinoma) and lymphoproliferative 
disorders[6].  Squamous cell carcinoma of the kidney in the context of a renal 
transplant and long-term immunosuppression has not previously been described in 
the literature.   
We describe a case of squamous cell carcinoma of a native kidney in a renal 





A 46-year-old white, British gentleman suffering from bilateral renal stone disease 
and recurrent urinary infections underwent a right nephrectomy.  Due to failure of 
the remaining left kidney, he required haemodialysis thrice-weekly via a left 
radiocephalic arteriovenous fistula for 18 months before receiving a deceased-donor 
renal transplant.  His past medical history included calcium pyrophosphate renal 
stone disease, secondary hyperparathyroidism and hypertension.  His regular 
medications were: Tacrolimus 2mg twice a day, prednisolone 5mg once a day, 
ferrous sulphate 200mg three times a day, paracetamol 1g four times a day and 
lansoprazole 30mg once a day.  The patient was a manual worker at a caravan site.  
He was a non-smoker, occasional alcohol drinker of 8 units per week and there was 
no renal disease in the family.   
Five years post-transplant, an abdominal ultrasound scan was performed due to 
recurrent urinary infections and ongoing pyuria.  This was reported as normal, but he 
later developed a discharging sinus in his left flank, which warranted a CT scan of his 
abdomen and pelvis.  This revealed a tracking peri-nephric abscess with an 
associated cystic lesion (13.0cm x 8.5cm x 9.5cm) of the left kidney.  A left 
nephrectomy was performed with histological examination demonstrating a cyst 
lined by stratified squamous epithelium, containing keratin within the lumen. Focal 
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invasion of the underlying lamina propria was present. There were areas of chronic 
inflammation associated with foreign body giant cell reaction, consistent with those 
of an epidermoid cyst. Further analysis revealed koilocytosis and coarse kertoyaline 
granules which were in keeping with a well differentiated but invasive squamous cell 
carcinoma arising from the collecting system of the left native kidney [FIGURE 1].  
P16 tumour suppressor protein staining was negative. Unfortunately the patient 
continued to suffer from left renal bed infections and further sinus formation, later 
requiring exploratory laparotomy, which revealed a chronic colonic perforation, and 
resulted in a left hemi-colectomy, splenectomy, and distal pancreatectomy.  Imaging 
of the patient’s lungs and spine revealed evidence of metastatic disease and a 
decision to manage palliatively was made, as he was too unwell to receive 
chemotherapy.  Palliative radiotherapy was required for bony metastases, which 




Squamous cell carcinoma of the kidney is a rare condition. It is associated with 
chronic irritation caused by renal stone disease and (chronic) infection, leading to 
squamous metaplasia.  Symptoms are non-specific, and diagnosis is often made late 
in the disease course resulting in a poor prognosis given the invasive nature of the 
condition.   
 
Renal transplant recipients are three-four times more likely to develop a malignancy 
[6].  It is thought the dose and duration of immunosuppression is a key-contributing 
factor to the increased risk of malignancy in these patients.  This is most likely due to 
impaired identification of tumour cells, direct oncogenic effects and diminished anti-
viral defense[7-8].  For example, calcineurin inhibitors such as tacrolimus have been 
demonstrated to stimulate transforming growth factor-β, interleukin-6 and vascular 
endothelial growth factor to promote tumour growth in animal models[9].  Given 
that this patient also had renal stone disease and recurrent urinary infection, he was 
at a greater risk of developing this condition. Unfortunately, both these conditions 
can mimic the non-specific symptoms of a squamous cell carcinoma of the kidney.  In 
the above case, the abdominal ultrasound was unhelpful and only a later CT scan of 
the abdomen revealed the underlying malignancy.  The UK Renal Association 
currently does not recommend annual ultrasound screening for evidence of native 
kidney malignancies (Evidence Level - 2C) [10].  They do recommend however, 
smoking cessation and immunosuppression minimisation.   
 
In patients with a renal transplant with renal stone disease or recurrent infections, 
the increased risk of squamous cell carcinoma should be considered. Given the non-
specific nature of the symptoms and the poor prognosis, healthcare professionals 
should have a lower threshold for diagnostic imaging.  This should be expedited if 










   
FIGURE 1: A well differentiated but invasive squamous cell carcinoma arising from 









Written informed consent was obtained from the patient described. 
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